Minerva Neurosciences (NERV) Return on Equity [ROE] (2014 - 2022)
Minerva Neurosciences (NERV) posted Return on Equity [ROE] of -1266.04% for Q1 2022, down 1279.60 percentage points from 13.56% a year earlier and down 1014.47 percentage points from the prior quarter.
Powered by 
Analysis
Minerva Neurosciences (NERV) Return on Equity [ROE] (2014 - 2022) Analysis & Trends
For FY2021, Minerva Neurosciences' Return on Equity [ROE] came in at -164.60%, down 169.43 percentage points from FY2020.
- Annual Return on Equity [ROE] shows a five-year change of -126.11 percentage points (FY2016 to FY2021).
- In prior years, Minerva Neurosciences' Return on Equity [ROE] was 4.83% in FY2020 (+127.12 pp), -122.30% in FY2019 (-77.07 pp), -45.23% in FY2018 (-18.71 pp) and -26.52% in FY2017 (+11.98 pp).
- The Q1 2022 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q3 2014.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last four quarters, with an average year-over-year change of -130.67 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2021, with a gain of 318.40 percentage points; the weakest was Q1 2022, with a drop of 1279.60 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -251.57% (Q4 2021), -97.35% (Q3 2021) and -78.11% (Q2 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Minerva Neurosciences | 158.21 Mn | 158.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | -1,266.04% |
| Dec 31, 2021 | -251.57% |
| Sep 30, 2021 | -97.35% |
| Jun 30, 2021 | -78.11% |
| Mar 31, 2021 | 13.56% |
| Dec 31, 2020 | 3.63% |
| Sep 30, 2020 | -39.76% |
| Jun 30, 2020 | -76.03% |
| Mar 31, 2020 | -304.85% |
| Dec 31, 2019 | -178.64% |
| Sep 30, 2019 | -90.31% |
| Jun 30, 2019 | -73.94% |
| Mar 31, 2019 | -63.87% |
| Dec 31, 2018 | -52.23% |
| Sep 30, 2018 | -43.34% |
| Jun 30, 2018 | -38.86% |
| Mar 31, 2018 | -33.32% |
| Dec 31, 2017 | -30.73% |
| Sep 30, 2017 | -35.32% |
| Jun 30, 2017 | -36.56% |
API Access
Minerva Neurosciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NERV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();